Indoco Remedies announced today that its Clinical Research Organisation, AnaCipher, located in Hyderabad, was inspected by the United States Food and Drug Administration from 12 to 16 September 2022. The clinical phase of inspection covered three BA/BE studies submitted by clients to the USFDA and was successfully concluded
with zero 483s.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
